1. Executive Summary
2. Global Prostate Health Market: Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2017 to 2028
3.1. Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
3.2. Global Prostate Health Market Trends (2017-2022) and Forecast (2023-2028)
3.3: Global Prostate Health Market by Disease Indication
3.3.1 Prostate Cancer
3.3.2 Prostatitis
3.3.3 Alpha Blockers
3.3.4 Benign Prostate Hyperplasia
3.3.5 Others
3.4: Global Prostate Health Market by Treatment Outlook
3.4.1 Cytotoxic Agents
3.4.2 Hormone ADT
3.4.3 AR Directed Therapies
3.4.4 PARP Inhibitors
3.4.5 Others
3.5: Global Prostate Health Market by Distribution Channel
3.5.1 Pharmacy
3.5.2 E-Commerce Stores
3.5.3 Others
4. Market Trends and Forecast Analysis by Region from 2017 to 2028
4.1: Prostate Health Market by Region
4.2: North American Prostate Health Market
4.2.1: North American Prostate Health Market by Disease Indication: Prostate Cancer, Prostatitis, Alpha Blockers, Benign Prostate Hyperplasia, and Others
4.2.2: North American Prostate Health Market by Distribution Channel: Pharmacy, E-Commerce Stores, and Others
4.3: European Prostate Health Market
4.3.1: European Prostate Health Market by Disease Indication: Prostate Cancer, Prostatitis, Alpha Blockers, Benign Prostate Hyperplasia, and Others
4.3.2: European Prostate Health Market by Distribution Channel: Pharmacy, E-Commerce Stores, and Others
4.4: APAC Prostate Health Market
4.4.1: APAC Prostate Health Market by Disease Indication: Prostate Cancer, Prostatitis, Alpha Blockers, Benign Prostate Hyperplasia, and Others
4.4.2: APAC Prostate Health Market by Distribution Channel: Pharmacy, E-Commerce Stores, and Others
4.5: ROW Prostate Health Market
4.5.1: ROW Prostate Health Market by Disease Indication: Prostate Cancer, Prostatitis, Alpha Blockers, Benign Prostate Hyperplasia, and Others
4.5.2: ROW Prostate Health Market by Distribution Channel: Pharmacy, E-Commerce Stores, and Others
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Prostate Health Market by Disease Indication
6.1.2: Growth Opportunities for the Global Prostate Health Market by Treatment Outlook
6.1.3: Growth Opportunities for the Global Prostate Health Market by Distribution Channel
6.1.4: Growth Opportunities for the Global Prostate Health Market by Region
6.2: Emerging Trends in the Global Prostate Health Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Prostate Health Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Prostate Health Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Eli Lilly and Company
7.2: Pfizer
7.3: Merck & Co.
7.4: Abbott
7.5: Endo Pharmaceuticals
7.6: GlaxoSmithKline PLC
7.7: Siemens Healthcare
7.8: Amgen
7.9: AstraZeneca